Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
9 Jul 2004
UCB has over 90% of Celltech Shares
Read More
24 Jun 2004
UCB Pharma* announces unique mode of action for Keppra ®
Read More
21 Jun 2004
UCB Pharma announces granting of European marketing authorisation for innovative transdermal therapy for symptomatic treatment of urge incontinence
Read More
8 Jun 2004
Annual General Meeting of UCB Shareholders
Read More
18 May 2004
Celltech and UCB Reach Worldwide Agreement on Development and Marketing of CDP870
Read More
18 May 2004
UCB S.A. launches a friendly offer to acquire Celltech Group plc, the leading UK-based biotech company
Read More
27 Apr 2004
UCB 44212, the second analogue of UCB Pharma’s anti-epileptic, KEPPRA*, enters clinical study phase
Read More
25 Mar 2004
UCB Group: confirmed increase of 2% in net results
Read More
22 Mar 2004
UCB Group : Keppra® Patent
Read More
6 Feb 2004
UCB Pharma announces partnership with Dynavax to develop and market products for the treatment of allergies
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
101
Page
102
Page
103
Page
104
Page
105
Page
106
Current page
107
Page
108
Page
109
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss